justETF App The best app for your ETF search! Download now

Xeris Biopharma Holdings

ISIN US98422E1038

WKN A3C4ZC

Overview

Description

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	435.36 m
EPS, EUR	-0.40
P/B ratio	110.04
P/E ratio	-
Dividend yield	0.00%

Income statement (2023)

Revenue, EUR	151.62 m
Net income, EUR	-57.58 m
Profit margin	-37.98%

What ETF is Xeris Biopharma Holdings in?

There are 5 ETFs which contain Xeris Biopharma Holdings. All of these ETFs are listed in the table below. The ETF with the largest weighting of Xeris Biopharma Holdings is the L&G Pharma Breakthrough UCITS ETF.

ETF	Weight	Investment focus	Holdings	TER	Fund size (in m EUR)	Return 1Y	WKN	ISIN
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.04%	Equity United States Health Care Biotech	214	0.35%	33	+24.66%	A2JDYM	IE00BDZVHG35
iShares Nasdaq US Biotechnology UCITS ETF	0.04%	Equity United States Health Care Biotech	214	0.35%	444	+25.65%	A2DWAW	IE00BYXG2H39
Xtrackers Russell 2000 UCITS ETF 1C	0.02%	Equity United States Small Cap	1,497	0.30%	1,841	+41.45%	A1XEJT	IE00BJZ2DD79
SPDR Russell 2000 US Small Cap UCITS ETF	0.01%	Equity United States Small Cap	1,802	0.30%	4,049	+41.48%	A1XFN1	IE00BJ38QD84
L&G Pharma Breakthrough UCITS ETF	3.03%	Equity World Health Care Innovation	37	0.49%	15	+8.11%	A2H9XR	IE00BF0H7608

Order fees

Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.

Order volume:

Order fee	Stock savings plans
0.99€	1000	View offer*
0.00€	2500	View offer*
0.00€	500	View offer*
0.00€	400	View offer*
5.90€	-	View offer*

Show all offers

Source: justETF Research; As of 11/2024; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.

Select your savings amount:

Broker	Rating	Execution fee	Account fee
		1.50€ 1.50%	0.00€	View offer*

Source: justETF Research; As of 11/2024; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.